89-014-060
B-cell CLL/lymphoma 9, Mouse, Clone: 2D4, Abnova™
Manufacturer: Abnova Corporation
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 89-014-060-Each-of-1 | In Stock | ₹ 51,397.50 |
89-014-060 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 51,397.50
GST (18%): ₹ 9,251.55
Total Price: ₹ 60,649.05
Antigen
B-cell CLL/lymphoma 9
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
PBS with no preservative; pH 7.4
Gene Accession No.
NM_004326
Gene Symbols
BCL9
Immunogen
BCL9 (NP_004317, 1036 a.a. ∼ 1135 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Quantity
100 μg
Research Discipline
Signal Transduction
Gene ID (Entrez)
607
Content And Storage
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Isotype
IgG1 κ
Applications
ELISA, Immunofluorescence, Western Blot
Clone
2D4
Description
Mouse monoclonal antibody raised against a partial recombinant BCL9.
Gene
BCL9
Gene Alias
LGS/MGC131591
Host Species
Mouse
Purification Method
Affinity Purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Related Products
Description
- BCL9 is associated with B-cell acute lymphoblastic leukemia
- It may be a target of translocation in B-cell malignancies with abnormalities of 1q21
- Its function is unknown
- The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies
- [provided by RefSeq Sequence: DDDSPPARSPNLPSMNNMPGMGINTQNPRISGPNPVVPMPTLSPMGMTQPLSHSNQMPSPNAVGPNIPPHGVPMGPGLMSHNPIMGHGSQEPPMVPQGRM